0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gene Therapy on Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-3X14503
Home | Market Reports | Health| Health Conditions| Cancer
Global Gene Therapy on Cancer Market Research Report 2023
BUY CHAPTERS

Gene Therapy on Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-3X14503
Report
October 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Therapy on Cancer - Market Size

The global market for Gene Therapy on Cancer was estimated to be worth US$ 4310.8 million in 2023 and is forecast to a readjusted size of US$ 45520 million by 2030 with a CAGR of 39.9% during the forecast period 2024-2030

Gene Therapy on Cancer - Market

Gene Therapy on Cancer - Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Therapy on Cancer, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Therapy on Cancer by region & country, by Type, and by Application.
The Gene Therapy on Cancer market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy on Cancer.
Market Segmentation

Scope of Gene Therapy on Cancer - Market Report

Report Metric Details
Report Name Gene Therapy on Cancer - Market
Forecasted market size in 2030 US$ 45520 million
CAGR 39.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Viral Gene Therapy
  • Non-viral Gene Therapy
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Gene Therapy on Cancer manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Gene Therapy on Cancer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Gene Therapy on Cancer in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Gene Therapy on Cancer - Market size in 2030?

Ans: The Gene Therapy on Cancer - Market size in 2030 will be US$ 45520 million.

Who are the main players in the Gene Therapy on Cancer - Market report?

Ans: The main players in the Gene Therapy on Cancer - Market are Novartis, Gilead Sciences, Amgen, Shanghai Sunway, Sibiono

What are the Application segmentation covered in the Gene Therapy on Cancer - Market report?

Ans: The Applications covered in the Gene Therapy on Cancer - Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Gene Therapy on Cancer - Market report?

Ans: The Types covered in the Gene Therapy on Cancer - Market report are Viral Gene Therapy, Non-viral Gene Therapy

1 Market Overview
1.1 Gene Therapy on Cancer Product Introduction
1.2 Global Gene Therapy on Cancer Market Size Forecast
1.3 Gene Therapy on Cancer Market Trends & Drivers
1.3.1 Gene Therapy on Cancer Industry Trends
1.3.2 Gene Therapy on Cancer Market Drivers & Opportunity
1.3.3 Gene Therapy on Cancer Market Challenges
1.3.4 Gene Therapy on Cancer Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Therapy on Cancer Players Revenue Ranking (2023)
2.2 Global Gene Therapy on Cancer Revenue by Company (2019-2024)
2.3 Key Companies Gene Therapy on Cancer Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Therapy on Cancer Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Therapy on Cancer
2.6 Gene Therapy on Cancer Market Competitive Analysis
2.6.1 Gene Therapy on Cancer Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Therapy on Cancer Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Cancer as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Viral Gene Therapy
3.1.2 Non-viral Gene Therapy
3.2 Global Gene Therapy on Cancer Sales Value by Type
3.2.1 Global Gene Therapy on Cancer Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Therapy on Cancer Sales Value, by Type (2019-2030)
3.2.3 Global Gene Therapy on Cancer Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Gene Therapy on Cancer Sales Value by Application
4.2.1 Global Gene Therapy on Cancer Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Therapy on Cancer Sales Value, by Application (2019-2030)
4.2.3 Global Gene Therapy on Cancer Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Therapy on Cancer Sales Value by Region
5.1.1 Global Gene Therapy on Cancer Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Therapy on Cancer Sales Value by Region (2019-2024)
5.1.3 Global Gene Therapy on Cancer Sales Value by Region (2025-2030)
5.1.4 Global Gene Therapy on Cancer Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Therapy on Cancer Sales Value, 2019-2030
5.2.2 North America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Therapy on Cancer Sales Value, 2019-2030
5.3.2 Europe Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Therapy on Cancer Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Therapy on Cancer Sales Value, 2019-2030
5.5.2 South America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Therapy on Cancer Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Therapy on Cancer Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Therapy on Cancer Sales Value
6.3 United States
6.3.1 United States Gene Therapy on Cancer Sales Value, 2019-2030
6.3.2 United States Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Therapy on Cancer Sales Value, 2019-2030
6.4.2 Europe Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Therapy on Cancer Sales Value, 2019-2030
6.5.2 China Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Therapy on Cancer Sales Value, 2019-2030
6.6.2 Japan Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Therapy on Cancer Sales Value, 2019-2030
6.7.2 South Korea Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Therapy on Cancer Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Therapy on Cancer Sales Value, 2019-2030
6.9.2 India Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Therapy on Cancer Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Profile
7.1.2 Novartis Main Business
7.1.3 Novartis Gene Therapy on Cancer Products, Services and Solutions
7.1.4 Novartis Gene Therapy on Cancer Revenue (US$ Million) & (2019-2024)
7.1.5 Novartis Recent Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Profile
7.2.2 Gilead Sciences Main Business
7.2.3 Gilead Sciences Gene Therapy on Cancer Products, Services and Solutions
7.2.4 Gilead Sciences Gene Therapy on Cancer Revenue (US$ Million) & (2019-2024)
7.2.5 Gilead Sciences Recent Developments
7.3 Amgen
7.3.1 Amgen Profile
7.3.2 Amgen Main Business
7.3.3 Amgen Gene Therapy on Cancer Products, Services and Solutions
7.3.4 Amgen Gene Therapy on Cancer Revenue (US$ Million) & (2019-2024)
7.3.5 Shanghai Sunway Recent Developments
7.4 Shanghai Sunway
7.4.1 Shanghai Sunway Profile
7.4.2 Shanghai Sunway Main Business
7.4.3 Shanghai Sunway Gene Therapy on Cancer Products, Services and Solutions
7.4.4 Shanghai Sunway Gene Therapy on Cancer Revenue (US$ Million) & (2019-2024)
7.4.5 Shanghai Sunway Recent Developments
7.5 Sibiono
7.5.1 Sibiono Profile
7.5.2 Sibiono Main Business
7.5.3 Sibiono Gene Therapy on Cancer Products, Services and Solutions
7.5.4 Sibiono Gene Therapy on Cancer Revenue (US$ Million) & (2019-2024)
7.5.5 Sibiono Recent Developments
8 Industry Chain Analysis
8.1 Gene Therapy on Cancer Industrial Chain
8.2 Gene Therapy on Cancer Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Therapy on Cancer Sales Model
8.5.2 Sales Channel
8.5.3 Gene Therapy on Cancer Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Gene Therapy on Cancer Market Trends
    Table 2. Gene Therapy on Cancer Market Drivers & Opportunity
    Table 3. Gene Therapy on Cancer Market Challenges
    Table 4. Gene Therapy on Cancer Market Restraints
    Table 5. Global Gene Therapy on Cancer Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Gene Therapy on Cancer Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Gene Therapy on Cancer Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Gene Therapy on Cancer Product Type
    Table 9. Key Companies Time to Begin Mass Production of Gene Therapy on Cancer
    Table 10. Global Gene Therapy on Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Cancer as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Gene Therapy on Cancer Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Gene Therapy on Cancer Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Gene Therapy on Cancer Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Gene Therapy on Cancer Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Gene Therapy on Cancer Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Gene Therapy on Cancer Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Gene Therapy on Cancer Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Gene Therapy on Cancer Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Gene Therapy on Cancer Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Gene Therapy on Cancer Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Gene Therapy on Cancer Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Gene Therapy on Cancer Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Gene Therapy on Cancer Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Gene Therapy on Cancer Sales Value by Region (2019-2024) & (%)
    Table 27. Global Gene Therapy on Cancer Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Gene Therapy on Cancer Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Gene Therapy on Cancer Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Gene Therapy on Cancer Sales Value, (2025-2030) & (US$ Million)
    Table 31. Novartis Basic Information List
    Table 32. Novartis Description and Business Overview
    Table 33. Novartis Gene Therapy on Cancer Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Gene Therapy on Cancer Business of Novartis (2019-2024)
    Table 35. Novartis Recent Developments
    Table 36. Gilead Sciences Basic Information List
    Table 37. Gilead Sciences Description and Business Overview
    Table 38. Gilead Sciences Gene Therapy on Cancer Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Gene Therapy on Cancer Business of Gilead Sciences (2019-2024)
    Table 40. Gilead Sciences Recent Developments
    Table 41. Amgen Basic Information List
    Table 42. Amgen Description and Business Overview
    Table 43. Amgen Gene Therapy on Cancer Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Gene Therapy on Cancer Business of Amgen (2019-2024)
    Table 45. Amgen Recent Developments
    Table 46. Shanghai Sunway Basic Information List
    Table 47. Shanghai Sunway Description and Business Overview
    Table 48. Shanghai Sunway Gene Therapy on Cancer Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Gene Therapy on Cancer Business of Shanghai Sunway (2019-2024)
    Table 50. Shanghai Sunway Recent Developments
    Table 51. Sibiono Basic Information List
    Table 52. Sibiono Description and Business Overview
    Table 53. Sibiono Gene Therapy on Cancer Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Gene Therapy on Cancer Business of Sibiono (2019-2024)
    Table 55. Sibiono Recent Developments
    Table 56. Key Raw Materials Lists
    Table 57. Raw Materials Key Suppliers Lists
    Table 58. Gene Therapy on Cancer Downstream Customers
    Table 59. Gene Therapy on Cancer Distributors List
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
    Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Gene Therapy on Cancer Product Picture
    Figure 2. Global Gene Therapy on Cancer Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 4. Gene Therapy on Cancer Report Years Considered
    Figure 5. Global Gene Therapy on Cancer Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Therapy on Cancer Revenue in 2023
    Figure 7. Gene Therapy on Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Viral Gene Therapy Picture
    Figure 9. Non-viral Gene Therapy Picture
    Figure 10. Global Gene Therapy on Cancer Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Gene Therapy on Cancer Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinic
    Figure 14. Product Picture of Other
    Figure 15. Global Gene Therapy on Cancer Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Gene Therapy on Cancer Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Gene Therapy on Cancer Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Gene Therapy on Cancer Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Gene Therapy on Cancer Sales Value (%), (2019-2030)
    Figure 28. United States Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Gene Therapy on Cancer Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Gene Therapy on Cancer Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Gene Therapy on Cancer Sales Value by Application (%), 2023 VS 2030
    Figure 49. Gene Therapy on Cancer Industrial Chain
    Figure 50. Gene Therapy on Cancer Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pelvic Cancer Drug Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17Y19082
Fri Jan 31 00:00:00 UTC 2025

Add to Cart

Global Cancer Treatment Support Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15F18979
Fri Jan 24 00:00:00 UTC 2025

Add to Cart

Global Precision Radiotherapy Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35E18717
Fri Jan 24 00:00:00 UTC 2025

Add to Cart

Global ICIs for Cervical Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35J18661
Thu Jan 23 00:00:00 UTC 2025

Add to Cart